- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-mer
- Ligands
- 28 x PEF: DI-PALMITOYL-3-SN-PHOSPHATIDYLETHANOLAMINE(Non-covalent)
PEF.1: 18 residues within 4Å:- Chain A: S.424, S.427, M.429
- Chain C: S.34, G.37, M.221, H.222, I.226, F.227, L.230
- Chain D: K.230
- Chain E: V.30, M.33, S.37
- Ligands: UQ6.4, CDL.5, PEF.10, PCF.18
Ligand excluded by PLIPPEF.6: 15 residues within 4Å:- Chain C: F.3, S.6, N.7, V.8, Y.9, L.10, V.13
- Chain M: T.112, N.115, V.116, I.119, M.193, M.196, I.203
- Ligands: UQ6.4
Ligand excluded by PLIPPEF.7: 10 residues within 4Å:- Chain A: N.279, H.319, F.320, W.431
- Chain C: A.2, F.3, V.13
- Chain J: R.17
- Ligands: UQ6.4, CDL.5
Ligand excluded by PLIPPEF.10: 20 residues within 4Å:- Chain C: V.41, I.42, V.45, N.74, I.77, L.81, M.237, A.241, F.245
- Chain D: L.208, K.211, T.212, I.215, L.216
- Chain E: G.40, A.41, S.43, T.44, T.47
- Ligands: PEF.1
Ligand excluded by PLIPPEF.13: 12 residues within 4Å:- Chain E: V.45, E.46, I.49, S.50, T.53
- Chain J: F.44, G.47, W.48, P.49
- Chain M: D.160, I.161, W.164
Ligand excluded by PLIPPEF.16: 8 residues within 4Å:- Chain C: V.320, L.321, F.324
- Chain G: K.40
- Chain H: K.52, S.53, L.56, Y.57
Ligand excluded by PLIPPEF.22: 16 residues within 4Å:- Chain K: S.424, S.427, M.429
- Chain M: S.34, M.221, H.222, I.226, F.227, L.230, M.237
- Chain N: K.230
- Chain O: M.33, S.37
- Ligands: CDL.19, PEF.28, PCF.35
Ligand excluded by PLIPPEF.23: 12 residues within 4Å:- Chain C: T.112, N.115, I.119, I.189, M.193, M.196
- Chain M: F.3, N.7, Y.9, L.10, V.13, I.195
Ligand excluded by PLIPPEF.24: 8 residues within 4Å:- Chain K: H.319, F.320, W.431
- Chain M: A.2, F.3, V.13
- Chain T: R.17
- Ligands: CDL.19
Ligand excluded by PLIPPEF.28: 14 residues within 4Å:- Chain M: V.41, I.42, N.74, M.237
- Chain N: L.208, K.211, T.212, I.215
- Chain O: G.40, S.43, T.44, T.47, F.48
- Ligands: PEF.22
Ligand excluded by PLIPPEF.31: 10 residues within 4Å:- Chain C: D.160, I.161, W.164
- Chain O: E.46, I.49, S.50, T.53
- Chain T: F.44, W.48, P.49
Ligand excluded by PLIPPEF.33: 10 residues within 4Å:- Chain M: V.320, L.321, I.370
- Chain Q: L.35, K.40
- Chain R: K.52, S.53, F.55, L.56, Y.57
Ligand excluded by PLIPPEF.41: 13 residues within 4Å:- Chain 2: K.10, V.13, I.14, F.21
- Chain U: F.268, F.321, L.324, A.325
- Chain V: I.60, I.66, I.69, W.70, F.73
Ligand excluded by PLIPPEF.42: 12 residues within 4Å:- Chain 5: A.56, V.57, F.60, S.61, K.62
- Chain U: V.423, Y.452, V.453, I.456
- Chain V: Y.6
- Ligands: PEF.50, PCF.51
Ligand excluded by PLIPPEF.43: 17 residues within 4Å:- Chain U: F.95, P.96, R.97, I.98, L.160
- Chain W: H.15, V.17, V.26, S.62, W.65, F.66, I.69, I.87, G.90, F.91, F.94
- Ligands: PEF.47
Ligand excluded by PLIPPEF.46: 16 residues within 4Å:- Chain 2: W.31, F.35
- Chain 5: L.51, P.54, G.55, Y.58
- Chain U: T.354, H.429, F.430, I.433, W.450
- Chain V: P.5, Y.6, C.8, M.29
- Chain Y: S.128
Ligand excluded by PLIPPEF.47: 16 residues within 4Å:- Chain W: F.66, I.69, V.70, A.73, T.74, I.87, M.222, V.225, R.229, H.234, T.236, H.239, H.240, V.241, G.242
- Ligands: PEF.43
Ligand excluded by PLIPPEF.48: 18 residues within 4Å:- Chain 4: T.105, L.106, F.107, N.113
- Chain U: T.208, L.212, F.216
- Chain W: I.101, Y.189, A.192, F.194, T.195, I.196, Y.206, A.207, G.210, L.211, L.214
Ligand excluded by PLIPPEF.50: 14 residues within 4Å:- Chain 5: W.53
- Chain U: L.334, L.339, I.342, F.414, W.415, F.418, I.419, V.423
- Chain V: S.40
- Chain Y: S.72, I.75, V.79
- Ligands: PEF.42
Ligand excluded by PLIPPEF.52: 13 residues within 4Å:- Chain 1: F.13, K.14, R.18, K.19, T.20, Y.22, S.25, F.29
- Chain U: F.19, M.20, Y.393, I.400, L.401
Ligand excluded by PLIPPEF.58: 15 residues within 4Å:- Chain 6: F.268, F.321, A.325
- Chain 7: M.42, I.60, I.66, I.69, W.70, F.73
- Chain e: K.10, V.13, I.14, I.17, V.18, F.21
Ligand excluded by PLIPPEF.59: 17 residues within 4Å:- Chain 6: F.95, P.96, R.97, I.98, L.160
- Chain 8: H.15, V.17, V.26, S.62, W.65, F.66, I.69, H.79, G.90, F.91, F.94
- Ligands: PEF.64
Ligand excluded by PLIPPEF.62: 18 residues within 4Å:- Chain 6: T.354, H.429, F.430, I.433, W.450
- Chain 7: T.4, P.5, Y.6, C.8, M.29
- Chain a: S.128
- Chain e: W.31, F.35
- Chain h: L.51, P.54, G.55, Y.58, A.63
Ligand excluded by PLIPPEF.63: 11 residues within 4Å:- Chain 6: V.423, V.453, I.456
- Chain 7: Y.6
- Ligands: PEF.67, PCF.68
- Chain h: A.56, V.57, F.60, S.61, K.62
Ligand excluded by PLIPPEF.64: 18 residues within 4Å:- Chain 8: F.66, I.69, V.70, A.73, T.74, I.87, F.91, M.218, M.222, R.229, H.234, T.236, H.239, H.240, V.241, G.242, T.245
- Ligands: PEF.59
Ligand excluded by PLIPPEF.65: 18 residues within 4Å:- Chain 6: T.208, L.212, F.216
- Chain 8: I.101, Y.189, A.192, F.194, T.195, I.196, Y.206, A.207, G.210, L.211, L.214
- Chain g: T.105, L.106, F.107, N.113
Ligand excluded by PLIPPEF.67: 13 residues within 4Å:- Chain 6: L.334, L.339, I.342, F.414, W.415, F.418, I.419
- Ligands: PEF.63
- Chain a: S.72, I.75, V.79
- Chain h: V.46, W.53
Ligand excluded by PLIPPEF.69: 12 residues within 4Å:- Chain 6: F.19, M.20, I.400, L.401
- Chain d: F.13, K.14, R.18, K.19, Y.22, S.25, H.26, F.29
Ligand excluded by PLIP- 4 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Non-covalent)
HEM.2: 22 residues within 4Å:- Chain C: L.40, Q.43, G.47, I.48, M.50, Y.54, V.65, R.79, H.82, A.83, A.86, F.89, T.127, G.131, Y.132, V.135, F.180, H.183, Y.184, P.187, I.190, Y.274
19 PLIP interactions:19 interactions with chain C,- Hydrophobic interactions: C:L.40, C:Q.43, C:I.48, C:Y.54, C:Y.54, C:V.65, C:A.83, C:F.89, C:F.89, C:T.127, C:F.180, C:Y.184, C:Y.184, C:I.190
- Salt bridges: C:R.79, C:R.79
- pi-Stacking: C:H.183
- Metal complexes: C:H.82, C:H.183
HEM.3: 23 residues within 4Å:- Chain C: W.30, G.33, S.34, L.36, G.37, F.89, M.93, H.96, M.97, K.99, S.105, L.113, W.114, G.117, V.118, I.120, F.121, V.194, H.197, L.198, L.201, S.206, S.207
18 PLIP interactions:18 interactions with chain C,- Hydrophobic interactions: C:L.36, C:L.36, C:F.89, C:L.113, C:W.114, C:V.118, C:I.120, C:F.121, C:L.198, C:L.201
- Hydrogen bonds: C:G.33, C:S.105, C:S.207
- Salt bridges: C:H.96, C:K.99, C:K.99
- Metal complexes: C:H.96, C:H.197
HEM.20: 22 residues within 4Å:- Chain M: L.40, Q.43, I.44, G.47, I.48, M.50, V.65, R.79, H.82, A.83, A.86, F.89, T.127, G.131, Y.132, V.135, F.180, H.183, Y.184, P.187, I.190, Y.274
16 PLIP interactions:16 interactions with chain M,- Hydrophobic interactions: M:L.40, M:Q.43, M:I.44, M:I.48, M:V.65, M:A.83, M:F.89, M:F.89, M:T.127, M:F.180, M:Y.184, M:Y.184, M:I.190
- Salt bridges: M:R.79
- Metal complexes: M:H.82, M:H.183
HEM.21: 21 residues within 4Å:- Chain M: W.30, G.33, S.34, L.36, G.37, F.89, H.96, M.97, K.99, S.105, L.113, W.114, G.117, V.118, I.120, F.121, V.194, H.197, L.201, S.206, S.207
18 PLIP interactions:18 interactions with chain M,- Hydrophobic interactions: M:L.36, M:L.36, M:F.89, M:L.113, M:V.118, M:I.120, M:F.121, M:L.201, M:L.201
- Hydrogen bonds: M:W.30, M:G.33, M:S.105, M:S.207
- Salt bridges: M:H.96, M:K.99, M:K.99
- Metal complexes: M:H.96, M:H.197
- 1 x UQ6: 5-(3,7,11,15,19,23-HEXAMETHYL-TETRACOSA-2,6,10,14,18,22-HEXAENYL)-2,3-DIMETHOXY-6-METHYL-BENZENE-1,4-DIOL(Non-covalent)
UQ6.4: 17 residues within 4Å:- Chain C: L.12, Y.16, I.17, L.40, V.41, I.44, V.45, I.48, V.194, I.195, L.198, M.199
- Chain M: L.12, Y.16
- Ligands: PEF.1, PEF.6, PEF.7
13 PLIP interactions:11 interactions with chain C, 2 interactions with chain M- Hydrophobic interactions: C:Y.16, C:I.17, C:L.40, C:V.41, C:I.44, C:V.45, C:I.48, C:V.194, C:I.195, C:L.198
- Hydrogen bonds: C:Y.16, M:Y.16, M:Y.16
- 8 x CDL: CARDIOLIPIN(Non-covalent)
CDL.5: 14 residues within 4Å:- Chain A: H.319, K.323, M.428, M.429, W.431
- Chain C: R.4, I.17, I.18, H.222
- Chain I: F.22
- Chain J: W.33
- Ligands: PEF.1, PEF.7, PCF.18
9 PLIP interactions:4 interactions with chain A, 1 interactions with chain I, 3 interactions with chain C, 1 interactions with chain J- Hydrogen bonds: A:M.429, A:W.431
- Salt bridges: A:H.319, A:K.323, C:R.4, C:H.222
- Hydrophobic interactions: I:F.22, C:I.17, J:W.33
CDL.12: 19 residues within 4Å:- Chain D: W.225
- Chain E: K.14, K.21, G.22, S.24, Y.25, F.28, M.29
- Chain H: Q.33, K.34, P.35
- Chain I: F.3, L.6, F.11
- Chain Y: K.77, A.80, L.84
- Ligands: CDL.15, PCF.17
14 PLIP interactions:2 interactions with chain I, 4 interactions with chain Y, 2 interactions with chain H, 6 interactions with chain E- Hydrophobic interactions: I:L.6, I:F.11, Y:K.77, Y:A.80, Y:L.84, E:F.28, E:F.28
- Salt bridges: Y:K.77, E:K.14, E:K.21, E:K.21
- Hydrogen bonds: H:Q.33, H:P.35, E:Y.25
CDL.14: 18 residues within 4Å:- Chain C: N.27, Y.28, W.29, M.32, L.35, F.88, M.91, V.92, M.95, L.235
- Chain G: H.85
- Chain H: A.43, S.47, R.50, F.51, Q.54
- Ligands: PCF.8, CDL.15
12 PLIP interactions:7 interactions with chain C, 4 interactions with chain H, 1 interactions with chain G- Hydrophobic interactions: C:L.35, C:F.88, C:F.88, C:V.92, C:L.235
- Hydrogen bonds: C:Y.28, C:W.29, H:R.50
- Salt bridges: H:R.50, H:R.50, H:R.50, G:H.85
CDL.15: 15 residues within 4Å:- Chain C: Y.28, L.235
- Chain D: Y.220, L.221, I.224, K.227, K.228
- Chain G: H.85
- Chain H: I.39, N.42, A.43, N.46, R.50
- Ligands: CDL.12, CDL.14
12 PLIP interactions:4 interactions with chain H, 5 interactions with chain D, 2 interactions with chain C, 1 interactions with chain G- Hydrogen bonds: H:N.46, H:R.50, H:R.50, C:Y.28, G:H.85
- Salt bridges: H:R.50, D:K.227, D:K.228, D:K.228
- Hydrophobic interactions: D:I.224, D:I.224, C:L.235
CDL.19: 13 residues within 4Å:- Chain K: H.319, K.323, D.425, M.428, M.429, W.431
- Chain M: R.4, I.18, H.222
- Chain T: W.33
- Ligands: PEF.22, PEF.24, PCF.35
9 PLIP interactions:3 interactions with chain M, 5 interactions with chain K, 1 interactions with chain T- Hydrophobic interactions: M:I.18, T:W.33
- Salt bridges: M:R.4, M:H.222, K:H.319, K:K.323
- Hydrogen bonds: K:M.429, K:W.431, K:W.431
CDL.27: 20 residues within 4Å:- Chain M: Y.28, V.231, L.235
- Chain N: S.218, Y.220, L.221, L.222, I.224, W.225, K.227, K.228
- Chain Q: H.85
- Chain R: I.39, N.42, A.43, N.46, S.47, R.50
- Ligands: CDL.30, CDL.32
14 PLIP interactions:5 interactions with chain R, 1 interactions with chain M, 8 interactions with chain N- Hydrophobic interactions: R:I.39, M:L.235, N:L.222, N:L.222, N:I.224, N:W.225
- Hydrogen bonds: R:N.46, R:R.50, R:R.50, N:Y.220
- Salt bridges: R:R.50, N:K.227, N:K.228, N:K.228
CDL.30: 15 residues within 4Å:- Chain N: W.225
- Chain O: K.14, K.21, G.22, Y.25, F.28, M.29
- Chain R: K.34, P.35, L.36, F.40
- Chain S: F.3, L.6, F.11
- Ligands: CDL.27
12 PLIP interactions:7 interactions with chain O, 2 interactions with chain S, 2 interactions with chain R, 1 interactions with chain a- Hydrophobic interactions: O:Y.25, O:F.28, S:L.6, S:F.11, R:F.40
- Hydrogen bonds: O:Y.25, R:P.35
- Salt bridges: O:K.14, O:K.21, O:K.21, O:K.21, a:K.77
CDL.32: 15 residues within 4Å:- Chain M: N.27, Y.28, W.29, F.88, M.91, M.95, F.236, I.239
- Chain Q: H.85
- Chain R: S.47, R.50, F.51, Q.54
- Ligands: PCF.25, CDL.27
9 PLIP interactions:5 interactions with chain M, 3 interactions with chain R, 1 interactions with chain Q- Hydrophobic interactions: M:F.88, M:F.88
- Hydrogen bonds: M:N.27, M:Y.28, M:W.29
- Salt bridges: R:R.50, R:R.50, R:R.50, Q:H.85
- 8 x PCF: 1,2-DIACYL-SN-GLYCERO-3-PHOSHOCHOLINE(Non-covalent)
PCF.8: 14 residues within 4Å:- Chain C: W.29, F.94, M.97, A.98, Y.102, Y.103, T.317, F.326, F.327, V.330
- Chain G: L.41, E.82
- Chain H: Q.54
- Ligands: CDL.14
9 PLIP interactions:7 interactions with chain C, 1 interactions with chain G, 1 interactions with chain H- Hydrophobic interactions: C:W.29, C:W.29, C:F.94, C:F.94, C:Y.102, C:F.326
- Hydrogen bonds: C:Y.103, H:Q.54
- Salt bridges: G:E.82
PCF.17: 9 residues within 4Å:- Chain H: G.38, F.40, H.41, V.44
- Chain Y: G.70, S.73, A.76, K.77
- Ligands: CDL.12
6 PLIP interactions:4 interactions with chain H, 2 interactions with chain Y- Hydrophobic interactions: H:V.44, Y:A.76
- Hydrogen bonds: H:G.38, H:F.40, H:H.41, Y:S.73
PCF.18: 16 residues within 4Å:- Chain A: W.401, D.402, S.427, M.429
- Chain E: Y.27, V.30, G.34, S.38, A.41
- Chain I: F.11, K.12, N.14, F.17, V.18
- Ligands: PEF.1, CDL.5
4 PLIP interactions:1 interactions with chain A, 1 interactions with chain I, 2 interactions with chain E- Salt bridges: A:D.402
- Hydrogen bonds: I:N.14
- Hydrophobic interactions: E:A.41
- pi-Cation interactions: E:Y.27
PCF.25: 20 residues within 4Å:- Chain M: W.29, F.94, M.95, M.97, A.98, Y.102, Y.103, T.317, F.326, F.327, V.330, F.331, F.333, V.334, Y.359
- Chain Q: L.41, E.82
- Chain R: Q.54, V.58
- Ligands: CDL.32
13 PLIP interactions:12 interactions with chain M, 1 interactions with chain R- Hydrophobic interactions: M:F.94, M:A.98, M:A.98, M:Y.102, M:F.326, M:F.327, M:F.331, M:F.333, M:V.334, M:V.334, R:V.58
- Hydrogen bonds: M:Y.103, M:Y.103
PCF.34: 8 residues within 4Å:- Chain R: Q.37, G.38, I.39, F.40, H.41, V.44
- Chain a: S.73, K.77
8 PLIP interactions:6 interactions with chain R, 2 interactions with chain a- Hydrophobic interactions: R:F.40, R:F.40, R:V.44, a:K.77
- Hydrogen bonds: R:G.38, R:F.40, R:H.41
- Salt bridges: a:K.77
PCF.35: 15 residues within 4Å:- Chain K: D.402, S.427, M.429
- Chain O: Y.27, V.30, G.34, S.38, A.41
- Chain S: F.11, K.12, N.14, F.17, V.18
- Ligands: CDL.19, PEF.22
4 PLIP interactions:2 interactions with chain O, 1 interactions with chain S, 1 interactions with chain K- Hydrophobic interactions: O:A.41
- pi-Cation interactions: O:Y.27
- Hydrogen bonds: S:N.14
- Salt bridges: K:D.402
PCF.51: 12 residues within 4Å:- Chain U: Q.46, Y.452, I.456
- Chain Y: G.88, A.91, V.92, R.94, M.95, G.97, G.98, D.100
- Ligands: PEF.42
6 PLIP interactions:3 interactions with chain Y, 3 interactions with chain U- Hydrophobic interactions: Y:V.92, U:Y.452, U:I.456
- Salt bridges: Y:R.94, Y:D.100
- Hydrogen bonds: U:Y.452
PCF.68: 9 residues within 4Å:- Chain 6: Y.452, I.456
- Ligands: PEF.63
- Chain a: F.90, A.91, R.94, M.95, G.98, D.100
4 PLIP interactions:3 interactions with chain 6, 1 interactions with chain a- Hydrophobic interactions: 6:I.456
- Hydrogen bonds: 6:Y.452, 6:Y.452
- Salt bridges: a:D.100
- 2 x HEC: HEME C(Covalent)
HEC.9: 23 residues within 4Å:- Chain D: V.39, C.40, C.43, H.44, N.108, A.111, L.112, P.113, P.114, L.116, I.119, R.123, Y.129, I.130, L.133, L.134, F.157, I.162, A.163, M.164, V.167, V.190, L.194
19 PLIP interactions:19 interactions with chain D,- Hydrophobic interactions: D:N.108, D:P.113, D:P.114, D:L.116, D:I.119, D:I.130, D:L.133, D:L.134, D:L.134, D:I.162, D:A.163, D:V.167, D:V.167, D:V.190, D:L.194
- Hydrogen bonds: D:Y.129, D:A.163
- Salt bridges: D:R.123
- Metal complexes: D:H.44
HEC.26: 22 residues within 4Å:- Chain N: V.35, V.39, C.40, C.43, H.44, N.108, L.112, P.113, P.114, L.116, I.119, R.123, Y.129, I.130, L.133, L.134, F.157, I.162, A.163, M.164, V.167, L.194
19 PLIP interactions:19 interactions with chain N,- Hydrophobic interactions: N:N.108, N:P.113, N:P.113, N:P.114, N:L.116, N:I.130, N:L.133, N:L.134, N:L.134, N:A.163, N:M.164, N:V.167, N:V.167, N:L.194
- Hydrogen bonds: N:Y.129, N:Y.129, N:A.163
- Salt bridges: N:R.123
- Metal complexes: N:H.44
- 2 x FES: FE2/S2 (INORGANIC) CLUSTER(Non-covalent)
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-mer
- Ligands
- 28 x PEF: DI-PALMITOYL-3-SN-PHOSPHATIDYLETHANOLAMINE(Non-covalent)
- 4 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Non-covalent)
- 1 x UQ6: 5-(3,7,11,15,19,23-HEXAMETHYL-TETRACOSA-2,6,10,14,18,22-HEXAENYL)-2,3-DIMETHOXY-6-METHYL-BENZENE-1,4-DIOL(Non-covalent)
- 8 x CDL: CARDIOLIPIN(Non-covalent)
- 8 x PCF: 1,2-DIACYL-SN-GLYCERO-3-PHOSHOCHOLINE(Non-covalent)
- 2 x HEC: HEME C(Covalent)
- 2 x FES: FE2/S2 (INORGANIC) CLUSTER(Non-covalent)